Point72 Asia (Singapore) Pte. Ltd. Rallybio Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Rallybio Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 22,119 shares of RLYB stock, worth $20,128. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,119
Previous 45,531
51.42%
Holding current value
$20,128
Previous $61 Million
57.58%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RLYB
# of Institutions
52Shares Held
31.9MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$3.82 Million0.02% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$3.31 Million1.36% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$3.3 Million1.69% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$3 Million3.98% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$2.76 Million0.08% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $29.2M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...